Evidence map›Paper›PMID 23747414›Full record

ArticleToxicology letters2013

Mechanism study of goldenseal-associated DNA damage.

Si Chen, Liqing Wan, Letha Couch, Haixia Lin, Yan Li, Vasily N Dobrovolsky, Nan Mei, Lei Guo

Open access · hybridAbstract read
In one paragraph

Article in Toxicology letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 55 citations in OpenAlex.

  1. Toxicity Potential of Nutraceuticals.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  2. Review
  3. Cholinesterase Inhibitory andCNS & neurological disorders drug targets · 2024
    Article
  4. Article
  5. The involvement of hepatic cytochrome P450s in the cytotoxicity of lapatinib.Toxicological sciences : an official journal of the Society of Toxicology · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Characterization of cytochrome P450s (CYP)-overexpressing HepG2 cells for assessing drug and chemical-induced liver toxicity.Journal of environmental science and health. Part C, Toxicology and carcinogenesis · 2021
    Article
  11. Review
  12. Article
  13. Using a Lentivirus-Based Inducible RNAi Vector to Silence a Gene.Methods in molecular biology (Clifton, N.J.) · 2020
    Article
  14. Systemic exposure to Ginkgo biloba extract in male F344/NCrl rats: Relevance to humans.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2019
    Article
  15. Finding the bad actor: Challenges in identifying toxic constituents in botanical dietary supplements.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2019
    Review
  16. Article
  17. Article
  18. Article
  19. Toxicology effects ofIranian journal of basic medical sciences · 2017
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Si ChenDivision of Biochemical Toxicology, National Center for Toxicological Research, U.S. FDA, Jefferson, AR 72079, USA.
Liqing Wan
Letha Couch
Haixia Lin
Yan Li
Vasily N Dobrovolsky
Nan Mei
Lei Guo
National Center for Toxicological Research · USUnited States Food and Drug Administration · US

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

Goldenseal has been used for the treatment of a wide variety of ailments including gastrointestinal disturbances, urinary tract disorders, and inflammation. The five major alkaloid constituents in goldenseal are berberine, palmatine, hydrastine, hydrastinine, and canadine. When goldenseal was evaluated by the National Toxicology Program (NTP) in the standard 2-year bioassay, goldenseal induced an increase in liver tumors in rats and mice; however, the mechanism of goldenseal-associated liver carcinogenicity remains unknown. In this study, the toxicity of the five goldenseal alkaloid constituents was characterized, and their toxic potencies were compared. As measured by the Comet assay and the expression of γ-H2A.X, berberine, followed by palmatine, appeared to be the most potent DNA damage inducer in human hepatoma HepG2 cells. Berberine and palmatine suppressed the activities of both topoisomerase (Topo) I and II. In berberine-treated cells, DNA damage was shown to be directly associated with the inhibitory effect of Topo II, but not Topo I by silencing gene of Topo I or Topo II. In addition, DNA damage was also observed when cells were treated with commercially available goldenseal extracts and the extent of DNA damage was positively correlated to the berberine content. Our findings suggest that the Topo II inhibitory effect may contribute to berberine- and goldenseal-induced genotoxicity and tumorigenicity.

Indexed as

AlkaloidsBerberineBerberine AlkaloidsComet AssayDNADNA DamageDNA Topoisomerases, Type IDNA Topoisomerases, Type IIGene Expression Regulation, EnzymologicGene SilencingHepatocytesHep G2 CellsHistonesHumansHydrastisMutagensAlkaloidsBerberineBerberine AlkaloidsDNADNA Topoisomerases, Type IDNA Topoisomerases, Type IIH2AX protein, humanHistonesMutagenspalmatinePlant ExtractsRNA, Small InterferingBerberineComet assayDNA damageGoldensealTopoisomeraseγ-H2A.X

Identifiers

PMID23747414
PMCPMC8686119
OpenAlexW2061702025

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.